Thursday, May 23, 2013
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Areas
Cover Stories
Reform to re-form
Nearing the anniversary of Obama’s health reform bill, we take a look at the plays that got pharma into the end zone.
Social media anxiety order
Phil Baumann outlines why the pharma industry needs to submerge itself into the binary world of social media.
The eye of the social storm
As the social media revolution continues its surge of success in the realms of digital marketing and communications, Nick Pryke takes a look...
Roundtables
-
Trends in outsourcing analytical support i...
David Beyerlein has over 11 years of experience managing laboratory operations, is an experienced analytical chemist, and is highly skilled in the use of the mass...Read more -
With David Beyerlein of MicroConstants, In...
With David Beyerlein of MicroConstants, Inc. and Dominic Moore of Waters CorporationRead more
Industry Analysts
-
Lost Batches – Nevermore: Rapping on the d...
Although the authors’ do not have statistics or a study to show the cause of the bulk of failures in single-use bioreactors, it is their strong feeling that the largest...Read more -
Closing the loop
As pharmaceutical companies are embracing the idea of closed-loop marketing, many are failing to realize its full benefits. Omar Chane, a Vice President in Capgemini...Read more -
In the sands of success
Marina Bay Sands will kick off 2011 with a series of highly anticipated openings and upcoming events include new trade shows such as Dye + Chem Asia International Expo 2010...Read more -
What’s your company’s innovation quotient©?
As innovation in the industry evolves to become all-encompassing, Navigator’s George Henderson invites a new train of thought to realign culture and push the envelope...Read more -
Asset management for the long term
At a time where the industry is treading water trying to work out its next route to future success, asset management is proving itself to be a pivotal player in keeping it...Read more -
Improving efficiency in bio-contamination ...
Improving efficiency in bio-contamination control and risk mitigation using hydrogen peroxide (h2o2) decontamination processes. By James Drinkwater.Read more
Executive Interviews
Balancing act: aligning competing strategic obj...
IMS offers insight to new commercial model and launch excellence initiatives.
Read more
REACH out for better
As the industry raises the bar once again to protect human health and the environment against chemical substances, Ali S. Faqi discusses the implications of the REACH initiative for manufacturers of chemical substances.
Read more
Below the surface
As companies continue to magnify their efforts in the realms of manufacturing, Jeffrey L. Mooney highlights the importance in utilizing sufficient surface technologies.
Read more
Next Generation Healthcare Summit
25th - 27th October 2010
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2013 GDS Publishing Ltd. All rights reserved.